Contract Manufacturing Wakunaga of America not only develops its own dietary supplement brands but also offers contract manufacturing services, presenting a potential B2B sales angle to private-label brands seeking reliable production partners.

Quality Credentials The company holds multiple quality certifications (cGMP NSF, TGA GMP, California Drug Manufacturing License, ISO 9001:2015, German Drug GMP), signaling a strong quality story to win contracts with retailers or brands prioritizing compliant and high-standard manufacturing.

Niche Brand Growth Recent product expansion such as the Kyolic Cardiovascular Health Vegan Formula 300 indicates ongoing product development in targeted wellness segments, offering opportunities to cross-sell or create co-branded formulations with retailers focused on plant-based cardiovascular support.

Mid-Market Focus With estimated revenue in the $25–$50 million range and a private family-owned structure, Wakunaga sits between smaller niche players and larger CPGs, making it an appealing partner for distributors and retailers seeking established yet flexible supplier relationships.

Strategic Partnerships Active media partnerships and visibility through Naturally Savvy and Whole Foods Magazine suggest opportunities to leverage joint marketing, influencer-affiliate campaigns, or co-promotional efforts to expand reach within health-conscious consumer segments.